| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/05/2026 | ±3.2% | +2.5% | over-priced |
| 05/01/2026 | ±5.4% | +0.6% | over-priced |
| 02/20/2026 | ±2.1% | -0.5% | over-priced |
| 11/05/2025 | ±2.7% | -15.2% | under-priced |
| 08/07/2025 | ±2.2% | +8.0% | under-priced |
| 05/05/2025 | ±1.9% | -11.6% | under-priced |
| 02/25/2025 | ±2.2% | +1.3% | over-priced |
| 10/30/2024 | ±1.6% | +5.7% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.03 | $2.2B | $198M |
| Q1 FY2026 | $1.22 | $2.1B | $238M |
| Q4 FY2025 | — | $2.2B | $139M |
| Q3 FY2025 | $1.16 | $2.0B | $231M |
ZBH (ZBH) reports in 6 days, with the next report estimated for 11/03/2026. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 5.7% on average — the market has been roughly fair on ZBH's earnings risk. Fundamentals into the print: EPS up 33.8% year-over-year, revenue up 4.8%. QuantLogix's live 5-factor engine currently reads ZBH as a buy at 66/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →